Retatrutide is an investigational triple-agonist peptide designed to activate: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors By targeting all three pathways, retatrutide addresses appetite regulation, insulin resistance, energy expenditure, and fat metabolism together rather than focusing on appetite suppression alone
Make sure to also have a record of the side effects that youve noticed or anything that might be significant during the time of your medication
1.Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE
they have recently pivoted away from most compounded GLP-1s to partner directly for brand-names like Zepbound and Wegovy, which are often prohibitively expensive without insurance coverage
Our team will help determine the most suitable treatment plan for you based on your health and weight loss goals